hotspot -WSS

hotspot

author：hotspot 2025-09-30 18:59:50 - browse：59

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Senators start work on Medicare physician payment reform

focus

WSS

BioMarin wins approval for gene therapy to treat hemophilia A

BioMarin wins approval for gene therapy to treat hemophilia A

ChatGPT in medicine: STAT answers readers' burning questions

What should King Charles tell the public about his cancer?

KalVista pill reduced swelling 'attacks' caused by genetic disease

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Wikipedia

hotspot

focus

Alkermes shareholders re

Key House Republican on health care plans exit from Congress

Tori Bowie and the unacceptable rates of Black maternal death

To avoid data mishandling cases, universities eye AI and other tools

23andMe had bad news about my health. I wish a person had delivered it

In age of alternative facts, a scholarly course on calling out crap

United colonoscopy coverage change 'may cost lives,' doctors say

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Medical leaders decry Supreme Court decision on affirmative action

How to save PrEP access — and even expand it

focus

Affirmative action in medical school literally saved lives

A disappointing year of Humira biosimilars

Industry veterans launch new biotech VC with $310M

Medical leaders decry Supreme Court decision on affirmative action

What should King Charles tell the public about his cancer?

At least 13 dead in Texas as scorching temps continue

hotspot

focus

explore

hotspot